Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 37,063 | 35,595 | 31,085 | 34,689 | 43,166 |
| Cost of Goods | 10,572 | 10,708 | 9,132 | 13,956 | 11,047 |
| Gross Profit | 26,491 | 24,887 | 21,953 | 20,733 | 32,118 |
| Operating Expenses | 41,812 | 42,047 | 54,034 | 53,211 | 54,910 |
| Operating Income | -14,749 | -16,452 | -31,949 | -31,522 | -22,745 |
| Interest Expense | 2,612 | 1,399 | 0 | 0 | 0 |
| Other Income | 8,762 | -4,559 | 1,888 | -2,383 | -2,550 |
| Pre-tax Income | -8,599 | -22,410 | -30,061 | -33,905 | -25,295 |
| Income Tax | -401 | -1,691 | -814 | -1,093 | -736 |
| Net Income Continuous | -8,198 | -20,719 | -29,247 | -32,813 | -24,559 |
| Net Income | $-8,198 | $-20,719 | $-29,247 | $-32,813 | $-24,559 |
| EPS Basic Total Ops | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 |
| EPS Basic Continuous Ops | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 |
| EPS Diluted Total Ops | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 |
| EPS Diluted Continuous Ops | -0.13 | -0.38 | -0.65 | -0.75 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.23 | -0.64 | -0.75 | -0.57 |
| EBITDA(a) | $-12,298 | $-14,327 | $-29,925 | $-30,390 | $-21,615 |